RONGLIN LI: Open Payments
NPI 1235518689 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 47 payments from 18 companies in 2025. Trend: 2023 $874 · 2024 $90 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $111 |
| Phathom Pharmaceuticals, Inc. | 4 | $87 |
| Lilly USA, LLC | 4 | $68 |
| PFIZER INC. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| Amgen Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $35 |
Products named: JARDIANCE, VOQUEZNA, FARXIGA, PREVNAR 20, AIRSUPRA, Kerendia, Cologuard Collection Kit, MOUNJARO.
Industry payments across CA — which companies pay providers there.
